Samuel Kintz

Person

Redwood City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2
- Patent number 11,807,649
- Issue date Nov 7, 2023
- EnLiven Therapeutics, Inc.
- Joseph P. Lyssikatos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kin...
- Patent number 11,807,638
- Issue date Nov 7, 2023
- ENLIVEN INC.
- Joseph P. Lyssikatos
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kin...
- Patent number 11,767,321
- Issue date Sep 26, 2023
- ENLIVEN INC.
- Joseph P. Lyssikatos
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1,7-diazacarbazoles and methods of use
- Patent number 9,440,976
- Issue date Sep 13, 2016
- Genentech, Inc.
- Hazel Joan Dyke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serine/threonine kinase inhibitors
- Patent number 9,388,171
- Issue date Jul 12, 2016
- Genetech, Inc.
- Jim Blake
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of use of diazacarbazoles for treating cancer
- Patent number 9,216,980
- Issue date Dec 22, 2015
- Genentech, Inc.
- Huifen Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 6,6-fused nitrogenous heterocyclic compounds and uses t...
- Patent number 9,206,175
- Issue date Dec 8, 2015
- Genentech, Inc.
- Joseph P. Lyssikatos
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazolines as serine/threonine kinase inhibitors
- Patent number 9,187,462
- Issue date Nov 17, 2015
- Array Biopharma Inc.
- James F. Blake
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 6,6-fused nitrogenous heterocyclic compounds and uses t...
- Patent number 8,623,889
- Issue date Jan 7, 2014
- Genentech, Inc.
- Joseph P. Lyssikatos
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diazacarbazoles and methods of use
- Patent number 8,501,765
- Issue date Aug 6, 2013
- Genentech, Inc.
- Huifen Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2
- Publication number 20240116921
- Publication date Apr 11, 2024
- EnLiven Therapeutics, Inc.
- Joseph P. LYSSIKATOS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
7-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES
- Publication number 20240043420
- Publication date Feb 8, 2024
- EnLiven Therapeutics, Inc.
- Joseph P. LYSSIKATOS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KIN...
- Publication number 20230382907
- Publication date Nov 30, 2023
- Enliven Inc.
- Joseph P. LYSSIKATOS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2
- Publication number 20230382923
- Publication date Nov 30, 2023
- EnLiven Therapeutics, Inc.
- Joseph P. LYSSIKATOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2
- Publication number 20230159557
- Publication date May 25, 2023
- EnLiven Therapeutics, Inc.
- Joseph P. LYSSIKATOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KIN...
- Publication number 20230130724
- Publication date Apr 27, 2023
- EnLiven Therapeutics, Inc.
- Joseph P. LYSSIKATOS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KIN...
- Publication number 20230065635
- Publication date Mar 2, 2023
- EnLiven Therapeutics, Inc.
- Joseph P. LYSSIKATOS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted 6,6-Fused Nitrogenous Heterocyclic Compounds and Uses T...
- Publication number 20160060262
- Publication date Mar 3, 2016
- Genentech, Inc.
- Joseph P. Lyssikatos
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,7-DIAZACARBAZOLES AND METHODS OF USE
- Publication number 20150328195
- Publication date Nov 19, 2015
- Genentech, Inc.
- Hazel Joan Dyke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF DIAZACARBAZOLES FOR TREATING CANCER
- Publication number 20150087630
- Publication date Mar 26, 2015
- Genentech, Inc.
- Huifen Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE COMPOUNDS AS SERINE/THREONINE KINASE INHIBITORS
- Publication number 20150087664
- Publication date Mar 26, 2015
- Genentech, Inc.
- James F. Blake
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,7-DIAZACARBAZOLES AND METHODS OF USE
- Publication number 20140171407
- Publication date Jun 19, 2014
- Genentech, Inc.
- Hazel Joan Dyke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 6,6-FUSED NITROGENOUS HETEROCYCLIC COMPOUNDS AND USES T...
- Publication number 20140088076
- Publication date Mar 27, 2014
- Genentech, Inc.
- Joseph P. Lyssikatos
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SERINE/THREONINE KINASE INHIBITORS
- Publication number 20140066453
- Publication date Mar 6, 2014
- Genentech, Inc.
- Jim Blake
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USE OF DIAZACARBAZOLES FOR TREATING CANCER
- Publication number 20130261104
- Publication date Oct 3, 2013
- Genentech, Inc.
- Huifen Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 6,6-FUSED NITROGENOUS HETEROCYCLIC COMPOUNDS AND USES T...
- Publication number 20120322785
- Publication date Dec 20, 2012
- Genentech, Inc.
- Joseph P. Lyssikatos
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAZACARBAZOLES AND METHODS OF USE
- Publication number 20110118230
- Publication date May 19, 2011
- Huifen Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Samuel Kintz

Person

Patents Grantslast 30 patents

Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2

5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kin...

5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kin...

1,7-diazacarbazoles and methods of use

Serine/threonine kinase inhibitors

Methods of use of diazacarbazoles for treating cancer

Substituted 6,6-fused nitrogenous heterocyclic compounds and uses t...

Substituted quinazolines as serine/threonine kinase inhibitors

Substituted 6,6-fused nitrogenous heterocyclic compounds and uses t...

Diazacarbazoles and methods of use

Patents Applicationslast 30 patents

LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2

7-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES

5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KIN...

FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2

FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2

5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KIN...

5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KIN...

Substituted 6,6-Fused Nitrogenous Heterocyclic Compounds and Uses T...

1,7-DIAZACARBAZOLES AND METHODS OF USE

METHODS OF USE OF DIAZACARBAZOLES FOR TREATING CANCER

QUINAZOLINE COMPOUNDS AS SERINE/THREONINE KINASE INHIBITORS

1,7-DIAZACARBAZOLES AND METHODS OF USE

SUBSTITUTED 6,6-FUSED NITROGENOUS HETEROCYCLIC COMPOUNDS AND USES T...

SERINE/THREONINE KINASE INHIBITORS

METHODS OF USE OF DIAZACARBAZOLES FOR TREATING CANCER

SUBSTITUTED 6,6-FUSED NITROGENOUS HETEROCYCLIC COMPOUNDS AND USES T...

DIAZACARBAZOLES AND METHODS OF USE